- Open Access
Interest of major serum protein removal for Surface-Enhanced Laser Desorption/Ionization – Time Of Flight (SELDI-TOF) proteomic blood profiling
© Roche et al; licensee BioMed Central Ltd. 2006
- Received: 20 June 2006
- Accepted: 05 October 2006
- Published: 05 October 2006
Surface-Enhanced Laser Desorption/Ionization – Time Of Flight (SELDI-TOF) has been proposed as new approach for blood biomarker discovery. However, results obtained so far have been often disappointing as this technique still has difficulties to detect low-abundant plasma and serum proteins.
We used a serum depletion scheme using chicken antibodies against various abundant proteins to realized a pre-fractionation of serum prior to SELDI-TOF profiling. Depletion of major serum proteins by immunocapture was confirmed by 1D and 2D gel electrophoresis. SELDI-TOF analysis of bound and unbound (depleted) serum fractions revealed that this approach allows the detection of new low abundant protein peaks with satisfactory reproducibility.
The combination of immunocapture and SELDI-TOF analysis opens new avenues into proteomic profiling for the discovery of blood biomarkers.
- Unbind Fraction
- Tris Buffer Solution
- ProteinChip Array
- Weak Cation Exchange
- ProteinChip Software
Human serum and plasma have an important clinical value for identification and detection of biomarkers. However, the analysis of these biological fluids is analytically challenging due to the high dynamic concentration range (over 10 orders of magnitude) of constituent protein/peptide species . In addition, the few most abundant blood proteins constitute 95% of the bulk mass of proteins but they represent less than 0.1% of the total number of proteins. These high abundant proteins, and in particular albumin, produce large signals in most proteomics approaches and they mask or interfere with the detection of the other low amount protein components. This situation explains why the discovery of new proteins or peptides biomarkers in blood is challenging. To minimize these problems, proteomics techniques are constantly improving to provide a wider range and an optimized detection of low concentration candidates [2, 3]. Many methods rely on a multidimensional separation scheme combining for example multidimensional chromatography or electrophoresis and mass spectrometry (MS) [4, 5]. This is the case of the Surface-Enhanced Laser Desorption/Ionization – Time Of Flight (SELDI-TOF) method [6, 7] that relies on MS to detect proteins and peptides initially selected by binding to various chromatographic surfaces (anionic, cationic, IMAC, hydrophobic). SELDI-TOF therefore focuses on a particular subset of the proteome for each of the capture conditions. However, results obtained so far with this technology have been often disappointing and controversial [8, 9]. In fact this technology still has difficulties to detect low-abundant plasma and serum proteins and could benefit from additional pre-fractionation methods of blood (for review see Issaq et al, ). Thus, liquid chromatography , binding to solid-phase libraries [12, 13] or enrichment of low molecular weight proteins  have been shown to improve SELDI-TOF analysis with however some drawback in terms of practicability, reproducibility, cost or difficulties to adapt to a high throughput approach.
Repeatability and reproducibility of SELDI-TOF spectra before and after immunocapture.
Minimum CV value
Maximum CV value
SELDI-TOF repeatability (p = 33)
SELDI-TOF reproducibility (p = 33)
Y12/SELDI-TOF repeatability (p = 31)
Y12/SELDI-TOF reproducibility (p = 30)
Summary of peak detection in the different fractions
Pearson Factor Between each replicate
Number of unique peaks
32 ± 1
29 ± 1
41 ± 0
Using CM10 ProteinChip, purified recombinant IL-8 could be detected as a 8,600 m/z peak (Figure 2e). We used this molecule spiked into the serum to illustrate the potency of the immunodepletion approach for the detection of low abundant proteins. Using a serum supplemented with 0.1 ng/μl of this recombinant IL-8 (11,4 pM), no obvious peak aligned with that of IL-8 was detectable when this it was directly analyzed by SELDI-TOF (Figure 2f). However, after Y12 immunodepletion and SELDI-TOF, a peak likely corresponding to IL-8, which was absent in non spiked serum (not shown), was readily detected in the unbound fraction (Figure 2g, star).
Removal of the major serum proteins using an immunocapture method allows the SELDI-TOF detection of new peaks, most likely corresponding to low abundant proteins, in the unbound fractions. In the bound fractions, major peaks were still detectable, as well as additional peaks corresponding to proteins co-purified with the 12 proteins retained by the columns. Taken together, our data showed that an approach combining immunocapture of major serum proteins followed by SELDI-TOF is reproducible, versatile, can be applied to a large number of samples and we believe presents a major interest for blood proteome analysis, profiling and biomarker discovery.
Anonymized serum samples that had a normal pattern on Hydragel (see below) were used for this study. Blood was initially collected in Vacutainer tubes without additive, let clot 30 minutes at room temperature and centrifuged for 30 min at 3000 × g. Serum was recovered and frozen at minus 80°C until used.
Fractionation of serum proteins was performed as recommended by the manufacturer (Beckmann, ref A24331). Briefly, 10 μL of serum was mixed with 490 μL of Tris buffer solution at pH 7.5 (TBS), added to IgY-microbead spin column and incubated at room temperature for 15 min with rotation. The unbound proteins were collected in a 2 mL eppendorf tube by centrifugation at 400 × g for 30 s. After 3 washes with TBS, bound proteins were eluted in two steps with 500 μL of stripping buffer (0.1 M Glycine, pH 2.5) and the fraction was then neutralised using 100 μL of 0.1 M TrisHCl pH 8. Concentration of the fraction to 40 μL was then realized by PES ultrafiltration (see below). Protein quantitation of the fractions demonstrated that 86% (± 6.5%) of the initial proteins was recovered with a distribution 84,3% (± 2.3%)/15.7% (± 2.3%) of bound/unbound proteins.
For Hydragel separation and 2D electrophoresis, the unbound and bound proteins were concentrated at 4°C on PES ultrafiltration columns with a 10 kDa cutoff (VIVASPIN 500, Vivascience ref VS0101) in 50 mM Tris pH 8.8. The Hydragel technology from Sebia (ref: 4115) allows the separation and the identification of major serum proteins for clinical application. 5 μL of serum were separated by electrophoresis on agarose following the kit procedure. The proteins were stained by acidic coomassie and the major protein identify by the banding pattern.
After the spin columns, samples were mixed with in 200 μL of solubilizing buffer (8 M urea, 1 M thiourea, 4.8% CHAPS, 50 mM DTT). Total protein quantitation was performed using PlusOne 2-D Quant Kit (Amersham Biosciences, ref 80-6483-56). For the first dimension, 20 μg of the samples were diluted in 125 μL of rehydratation buffer (9.8 M urea 4% CHAPS 50 mM DTT and 0.5% IPG buffer 4–7). 7 cm IPG strips (Amersham ref 17-6001-10), covering a pH range of 4 – 7 were rehydrated with this solution during 18 h under low viscosity paraffin oil. For focalisation, the following voltage/time profile was used on a IPG Phor II: 300 V for 2 h, a gradient until 1000 V for 1 h, a gradient until 5000 V for 1 h 30 and 5000 V during 3 h 30. A total of 23250 vh was achieved. For the second dimension, strips were equilibrated for 30 min in 6 M urea, 30% glycerol, 2% SDS, 50 mM Tris pH 8.8,1%DTTand then incubated for an additional 30 min in the same solution except that DTT was replaced by 5% iodoacetamide. After equilibration, proteins were separated in the second dimension in 4–12% NuPAGE gels (Invitrogen). Gels were stained with a modified silver nitrate procedure as in Shevchenko et al . Gels were scanned at 300 dots per inch using Labscan 3 software after a procedure of calibration using kaleidoscope LaserSoft Imaging (Kodak, ref: R020123).
For SELDI-TOF analysis, the total unbound and bound proteins obtained from 10 μl of serum were concentrated to 40 μl by a 45 min centrifugation at 4°C on PES ultrafiltration columns with a 3 KDa cutoff (Millipore, ref 42403). 1 μl of the initial serum, 12 and 4 μl out of the 40 μl unbound and bound fractions were used for analysis. These volumes have been chosen experimentally after optimization. These samples were diluted 1.5 time with a solution of 8 M Urea, 1% CHAPS and shaken 15 min at room temperature. Denaturated samples were then mixed with 100 μL of binding buffer (100 mM Ammonium Acetate pH4, 0.1% Triton) for application on CM10 (weak cation exchange) ProteinChip (Ciphergen, Fremont, CA). CM10 ProteinChips arrays were pre-equilibrated with 150 μL of binding buffer using in 96 wells bioprocessor and incubated 5 min with gentle agitation. After removing binding buffers from the wells, denaturated samples were added and incubated for 1 h on a plate shaker at room temperature. The wells were washed two times with the binding buffer and one time with 100 mM Ammonium Acetate pH4 during 5 min, followed by a final brief rinse with water. ProteinChip arrays were removed from the bioprocessor and air-dried. Finally, 0.8 μL of saturated sinapinic acid solution was applied twice to each spot and the chips were allowed to air-dry again.
Mass spectrometric analysis was performed by SELDI-TOF in a PBS-II ProteinChip reader (Ciphergen Biosystems) using the same settings for all the samples and for data collection (calibration, focusing mass, laser intensity and detector sensitivity). Each spectrum was an average of at least 100 laser shots. Externally calibration was done with the All-in-1 Protein Standard II (Ciphergen Biosystems). Spectra analysis was carried out using using the ProteinChip software version 3.2 (Ciphergen Biosystems). The background was subtracted using the default software settings. Peaks with a ratio signal/noise above 3 were identified by the ProteinChip Software. After normalization on Total Ion Current (TIC) and quantification, the data were exported to Hierarchical Clustering Explorer Software (HCE v3 ). Clusters were processed using Pearson statistical test.
IL-8 spiking experiment
Human recombinant IL-8 (Calbiochem, ref 407673) was aliquoted at 10 μg/mL in PBS and stored at -80°C. 2.5 μL (25 ng) of this material was analysed by SELDI-TOF to find the corresponding IL-8 peak. For the spiking experiment, 0.1 ng of IL-8 was added per μl of serum (11.4 pM) which was then analysed directly of after immunodepletion as described above.
We thank Prof. Jean-Paul Cristol for his support.
- Anderson NL, Anderson NG: The human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics 2002, 1(11):845–867. 10.1074/mcp.R200007-MCP200View ArticlePubMedGoogle Scholar
- Rai AJ, Stemmer PM, Zhang Z, Adam BL, Morgan WT, Caffrey RE, Podust VN, Patel M, Lim LY, Shipulina NV, Chan DW, Semmes OJ, Leung HC: Analysis of Human Proteome Organization Plasma Proteome Project (HUPO PPP) reference specimens using surface enhanced laser desorption/ionization-time of flight (SELDI-TOF) mass spectrometry: multi-institution correlation of spectra and identification of biomarkers. Proteomics 2005, 5(13):3467–3474. 10.1002/pmic.200401320View ArticlePubMedGoogle Scholar
- States DJ, Omenn GS, Blackwell TW, Fermin D, Eng J, Speicher DW, Hanash SM: Challenges in deriving high-confidence protein identifications from data gathered by a HUPO plasma proteome collaborative study. Nat Biotech 2006, 24(3):333–338. 10.1038/nbt1183View ArticleGoogle Scholar
- Pieper R, Gatlin CL, Makusky AJ, Russo PS, Schatz CR, Miller SS, Su Q, McGrath AM, Estock MA, Parmar PP, Zhao M, Huang ST, Zhou J, Wang F, Esquer-Blasco R, Anderson NL, Taylor J, Steiner S: The human serum proteome: display of nearly 3700 chromatographically separated protein spots on two-dimensional electrophoresis gels and identification of 325 distinct proteins. Proteomics 2003, 3(7):1345–1364. 10.1002/pmic.200300449View ArticlePubMedGoogle Scholar
- Yang Z, Hancock WS, Chew TR, Bonilla L: A study of glycoproteins in human serum and plasma reference standards (HUPO) using multilectin affinity chromatography coupled with RPLC-MS/MS. Proteomics 2005, 5(13):3353–3366. 10.1002/pmic.200401190View ArticlePubMedGoogle Scholar
- Clarke CH, Buckley JA, Fung ET: SELDI-TOF-MS proteomics of breast cancer. Clin Chem Lab Med 2005, 43(12):1314–1320. 10.1515/CCLM.2005.225PubMedGoogle Scholar
- Tang N, Tornatore P, Weinberger SR: Current developments in SELDI affinity technology. Mass Spectrom Rev 2004, 23(1):34–44. 10.1002/mas.10066View ArticlePubMedGoogle Scholar
- Coombes KR, Morris JS, Hu J, Edmonson SR, Baggerly KA: Serum proteomics profiling--a young technology begins to mature. Nat Biotechnol 2005, 23(3):291–292. 10.1038/nbt0305-291View ArticlePubMedGoogle Scholar
- Coombes KR: Analysis of mass spectrometry profiles of the serum proteome. Clin Chem 2005, 51(1):1–2. 10.1373/clinchem.2004.040832View ArticlePubMedGoogle Scholar
- Issaq HJ, Conrads TP, Janini GM, Veenstra TD: Methods for fractionation, separation and profiling of proteins and peptides. Electrophoresis 2002, 23(17):3048–3061. 10.1002/1522-2683(200209)23:17<3048::AID-ELPS3048>3.0.CO;2-LView ArticlePubMedGoogle Scholar
- Guerrier L, Lomas L, Boschetti E: A simplified monobuffer multidimensional chromatography for high-throughput proteome fractionation. J Chromatogr 2005, 1073(1–2):25–33. 10.1016/j.chroma.2004.10.002View ArticleGoogle Scholar
- Guerrier L, Thulasiraman V, Castagna A, Fortis F, Lin S, Lomas L, Righetti PG, Boschetti E: Reducing protein concentration range of biological samples using solid-phase ligand libraries. J Chromatogr 2006, 833(1):33–40. 10.1016/j.jchromb.2005.12.048Google Scholar
- Thulasiraman V, Lin S, Gheorghiu L, Lathrop J, Lomas L, Hammond D, Boschetti E: Reduction of the concentration difference of proteins in biological liquids using a library of combinatorial ligands. Electrophoresis 2005, 26(18):3561–3571. 10.1002/elps.200500147View ArticlePubMedGoogle Scholar
- Orvisky E, Drake SK, Martin BM, Abdel-Hamid M, Ressom HW, Varghese RS, An Y, Saha D, Hortin GL, Loffredo CA, Goldman R: Enrichment of low molecular weight fraction of serum for MS analysis of peptides associated with hepatocellular carcinoma. Proteomics 2006, 6(9):2895–2902. 10.1002/pmic.200500443View ArticlePubMedGoogle Scholar
- Leatherbarrow RJ, Dean PD: Studies on the mechanism of binding of serum albumins to immobilized cibacron blue F3G A. Biochem J 1980, 189(1):27–34.PubMed CentralView ArticlePubMedGoogle Scholar
- Maccarrone G, Milfay D, Birg I, Rosenhagen M, Holsboer F, Grimm R, Bailey J, Zolotarjova N, Turck CW: Mining the human cerebrospinal fluid proteome by immunodepletion and shotgun mass spectrometry. Electrophoresis 2004, 25(14):2402–2412. 10.1002/elps.200305909View ArticlePubMedGoogle Scholar
- Bjorhall K, Miliotis T, Davidsson P: Comparison of different depletion strategies for improved resolution in proteomic analysis of human serum samples. Proteomics 2005, 5(1):307–317. 10.1002/pmic.200400900View ArticlePubMedGoogle Scholar
- Huang L, Harvie G, Feitelson JS, Gramatikoff K, Herold DA, Allen DL, Amunngama R, Hagler RA, Pisano MR, Zhang WW, Fang X: Immunoaffinity separation of plasma proteins by IgY microbeads: meeting the needs of proteomic sample preparation and analysis. Proteomics 2005, 5(13):3314–3328. 10.1002/pmic.200401277View ArticlePubMedGoogle Scholar
- Shevchenko A, Wilm M, Vorm O, Mann M: Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal Chem 1996, 68(5):850–858. 10.1021/ac950914hView ArticlePubMedGoogle Scholar
- Seo J, Bakay M, Chen YW, Hilmer S, Shneiderman B, Hoffman EP: Interactively optimizing signal-to-noise ratios in expression profiling: project-specific algorithm selection and detection p-value weighting in Affymetrix microarrays. Bioinformatics 2004, 20(16):2534–2544. 10.1093/bioinformatics/bth280View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.